Hyderabad-based startup harnesses AI to develop treatment for psoriasis

HYDERABAD: Acubiosys Private Limited, a Hyderabad-based biotech startup, has developed two artificial intelligence- and nanotechnology-enabled phytomedicines aimed at treating psoriasis and diabetic wound care. The startup, incubated at the BRIC-Centre for DNA Fingerprinting and Diagnostics (BRIC-CDFD) Technology Incubator, focuses on developing evidence-based natural and synthetic therapeutics for autoimmune diseases, skin disorders and chronic wound management, such as psoriasis, atopic dermatitis and diabetic foot ulcers-ailments that often require long-term treatment and continue to pose significant healthcare challenges.